737713-28-9

Basic information

• Product Name: [(R)-1-(3,5-Dimethylphenyl)ethyl]amine
• Synonyms: [(R)-1-(3,5-Dimethylphenyl)ethyl]amine;Benzenemethanamine, α,3,5-trimethyl-, (αR)-;(1R)-1-(3,5-DIMETHYLPHENYL)ETHYLAMINE-HCl;5-triMethyl-;(1R)-1-(3,5-DiMethylphenyl)ethylaMine hydrochloride;(1R)-1-(3,5-diMethylphenyl)ethanaMine
• CAS NO: 737713-28-9
• Molecular Formula: C10H15N
• Molecular Weight: 149.23
• Product Categories: API intermediates
• Mol File: 737713-28-9.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 226.064°C at 760 mmHg
• Flash Point: 93.691°C
• Appearance: /
• Density: 0.937g/cm³
• Vapor Pressure: 0.084mmHg at 25°C
• Refractive Index: 1.527
• CAS DataBase Reference: [(R)-1-(3,5-Dimethylphenyl)ethyl]amine(CAS DataBase Reference)
• NIST Chemistry Reference: [(R)-1-(3,5-Dimethylphenyl)ethyl]amine(737713-28-9)
• EPA Substance Registry System: [(R)-1-(3,5-Dimethylphenyl)ethyl]amine(737713-28-9)

Safety Data

• Hazardous Substances Data: 737713-28-9(Hazardous Substances Data)

Usage

General Description

[(R)-1-(3,5-Dimethylphenyl)ethyl]amine is a chemical compound that belongs to the class of organic compounds known as benzene and substituted derivatives. These are aromatic compounds containing one monocyclic ring system made up of benzene. The 'R' in its name indicates the configuration of the compound’s chirality center, representing its spatial arrangement. The compound features a dimethylphenyl group, which is a phenyl group substituted with two methyl groups at the 3rd and 5th positions, along with an ethyl and an amine group. Its precise properties (such as melting point, boiling point, toxicity etc.) can vary based on the presence of other substituent groups/atoms or specific conditions it is subjected to.

InChI:InChI=1/C10H15N/c1-7-4-8(2)6-10(5-7)9(3)11/h4-6,9H,11H2,1-3H3/t9-/m1/s1

Upstream product

• 5379-16-8 3,5-dimethylacetophenone 
• 84520-44-5 (S)-α-(3,5-dimethylphenyl)ethylamine L-O,O'-dibenzoyltartrate 

Relevant articles and documents

ISOQUINOLINE COMPOUNDS, A PROCESS FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

A compound of formula (I): wherein the substituents are as defined in the description. Medicinal products containing the same which are useful in treating or preventing pathologies which are the result of activation of the RhoA/ROCK pathway and phosphorylation of the myosin light chain.

Substituted Tetrahydroimidazopyridine Compounds and the Use Thereof in the Treatment of Pain and Other Conditions

Substituted tetrahydroimidazopyridine compounds corresponding to formula I: in which R1, R2 and R3 have defined meanings, processes for preparing such compounds, pharmaceutical compositions containing such compounds, and t